Marino, Stram & Associates LLC Amgen Inc Transaction History

Marino, Stram & Associates LLC

$445 Million
Q3 2024

A detailed history of Marino, Stram & Associates LLC transactions in Amgen Inc stock. As of the latest transaction made, Marino, Stram & Associates LLC holds 4,824 shares of AMGN stock, worth $1.42 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

4,824

Previous 4,793 0.65%

Holding current value

$1.42 Million

Previous $1.5 Million 3.81%

% of portfolio

0.35%

Previous 0.37%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$309.38 - $337.38 $9,590 - $10,458	31 Added 0.65%	4,824 $1.55 Million
Q2 2024 Jul 18, 2024	SELL	$262.75 - $319.31 $1,051 - $1,277	-4 Reduced 0.08%	4,793 $1.5 Million
Q1 2024 Apr 24, 2024	BUY	$268.87 - $324.56 $45,976 - $55,499	171 Added 3.7%	4,797 $1.36 Million
Q4 2023 Jan 30, 2024	BUY	$255.7 - $288.46 $8,693 - $9,807	34 Added 0.74%	4,626 $1.33 Million
Q3 2023 Oct 30, 2023	BUY	$218.65 - $271.46 $20,115 - $24,974	92 Added 2.04%	4,592 $1.23 Million
Q2 2023 Jul 20, 2023	SELL	$214.27 - $253.37 $53,781 - $63,595	-251 Reduced 5.28%	4,500 $999,000
Q1 2023 Apr 20, 2023	BUY	$225.79 - $275.2 $86,025 - $104,851	381 Added 8.72%	4,751 $1.15 Million
Q4 2022 Jan 19, 2023	BUY	$229.03 - $291.01 $25,880 - $32,884	113 Added 2.65%	4,370 $0
Q3 2022 Oct 17, 2022	BUY	$224.46 - $253.15 $55,217 - $62,274	246 Added 6.13%	4,257 $959,000
Q2 2022 Jul 15, 2022	SELL	$230.71 - $256.74 $692 - $770	-3 Reduced 0.07%	4,011 $976,000
Q1 2022 Apr 25, 2022	BUY	$219.27 - $242.57 $6,797 - $7,519	31 Added 0.78%	4,014 $971,000
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $29,434 - $33,684	148 Added 3.86%	3,983 $896,000
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $618,130 - $724,214	-2,912 Reduced 43.16%	3,835 $816,000
Q2 2021 Jul 22, 2021	BUY	$233.58 - $259.14 $779,456 - $864,750	3,337 Added 97.86%	6,747 $1.64 Million
Q1 2021 Apr 26, 2021	BUY	$221.91 - $258.6 $80,331 - $93,613	362 Added 11.88%	3,410 $848,000
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $65,779 - $78,331	304 Added 11.08%	3,048 $701,000
Q3 2020 Oct 22, 2020	BUY	$234.65 - $260.95 $29,096 - $32,357	124 Added 4.73%	2,744 $698,000
Q2 2020 Jul 20, 2020	BUY	$197.81 - $242.74 $155,083 - $190,308	784 Added 42.7%	2,620 $618,000
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $34,078 - $45,197	187 Added 11.34%	1,836 $372,000
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $2,270 - $2,918	12 Added 0.73%	1,649 $398,000
Q2 2019 Jul 19, 2019	BUY	$166.7 - $195.41 $110,355 - $129,361	662 Added 67.9%	1,637 $302,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $41,600 - $46,892	230 Added 30.87%	975 $185,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $9,464 - $10,631	57 Added 8.28%	745 $138,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $26,261 - $30,690	155 Added 29.08%	688 $117,000
Q4 2017 Mar 09, 2018	BUY	$168.79 - $188.59 $89,965 - $100,518	533	533 $93,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marino, Stram & Associates LLC with notifications on news.

Account

Marino, Stram & Associates LLC Amgen Inc Transaction History